National Pharmaceutical Industries Company SAOG financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
1.85M | 2.37M | 2.68M | 2.99M | 3.61M | 7.61M | 5.74M | 6.36M | 7.10M | 9.23M | 10.04M | 10.61M | 13.22M | 15.37M | 0.00M | 0.00M |
| GM % | Gross Margin % |
|
-22.45% | -0.99% | 1.60% | 8.25% | 10.77% | 26.90% | 27.91% | 25.22% | 30.43% | 33.61% | 35.06% | 39.34% | 40.56% | 41.78% | 0.00% | 0.00% |
| OM | Operating Margin |
|
-51.19% | -25.01% | -22.91% | -15.83% | -12.99% | 3.65% | 7.29% | 10.58% | 11.61% | 13.04% | 12.14% | 12.93% | 13.41% | 15.41% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | |||||||||||||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
30.31m | 30.31m | 30.31m | 30.31m | 30.31m | 50m | 50m | 50m | 50m | 50m | 50m | 50m | 50m | 50m | 99.76m | 0m |
| OCF | Operating Cash Flow |
|
-0.99M | 0.10M | -1.11M | -0.19M | -2.26M | 0.77M | 1.53M | 0.11M | 0.25M | 0.49M | 1.80M | 0.84M | 1.00M | -0.86M | 0.00M | 0.00M |
| FCF | Free Cash Flow |
|
-1.06M | 0.04M | -1.17M | -0.20M | -2.31M | 0.48M | 1.20M | -0.06M | -0.07M | 0.27M | 1.35M | 0.14M | 0.14M | -2.24M | 0.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
-0.03 | 0.00 | -0.04 | -0.00 | -0.03 | 0.01 | 0.02 | -0.00 | -0.00 | 0.00 | 0.02 | 0.00 | 0.00 | -0.05 | 0.00 | 0.00 |